AUPH 8-K 2026-10-30

Aurinia Pharmaceuticals Inc. (AUPH) 8-K dated 2026-10-30 — accession 0001600620-26-000074. This URL is the filing, not the AUPH hub.

Aurinia Pharmaceuticals Inc. (AUPH) is a biotechnology company listed on US.

Aurinia Pharmaceuticals Inc. filed a 8-K on 2026-10-30. Accession 0001600620-26-000074.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported AUPH revenue for 2026-06-30 was $83.2M. Net income was $37.4M. Revenue was up 7.1% from 2026-03-31 to 2026-06-30. AUPH currently screens at market cap $1.03B.

Not investment advice. The AUPH SEC hub lists recent forms. The stock page is the research view.